Christoph Correll discussed Neumora Therapeutics' promising M4 receptor targeting approach and scientific ties in Germany.
1 report, 0 independent
Updated Jul 9
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Christoph Correll discussed Neumora Therapeutics' promising M4 receptor targeting approach and scientific ties in Germany.
Who's involved
What this event is mainly aboutNeumora Therapeutics, Inc.Christoph Correll
Keep exploring
The entities involved
-
Neumora Therapeutics, Inc.
biopharmaceutical company
Nothing else this week.
Coverage
Newest first; wire copies grouped- Unknown outlet